Literature DB >> 6480830

Catabolism of very low density lipoproteins in experimental nephrosis.

D W Garber, B A Gottlieb, J B Marsh, C E Sparks.   

Abstract

The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480830      PMCID: PMC425305          DOI: 10.1172/JCI111548

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  ADIPOSE TISSUE IN EXPERIMENTAL NEPHROTIC SYNDROME.

Authors:  A GUTMAN; E SHAFRIR
Journal:  Am J Physiol       Date:  1963-10

2.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

3.  Tissue distribution of C-14 after the intravenous injection of labeled free fatty acids and chylomicrons in nephrotic rats.

Authors:  C L MALMENDIER
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

4.  Effect of albumin on products formed from chylomicron triacylclycerol by lipoprotein lipase in vitro.

Authors:  R O Scow; T Olivecrona
Journal:  Biochim Biophys Acta       Date:  1977-06-22

5.  Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains.

Authors:  S E Lux; K M John; H B Brewer
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  Effect of experimental hypertriglyceridaemia on tissue and serum lipoprotein lipase activity.

Authors:  E Shafrir; Y Biale
Journal:  Eur J Clin Invest       Date:  1970-03       Impact factor: 4.686

7.  Metabolic heterogeneity of apolipoprotein B in the rat.

Authors:  C E Sparks; J B Marsh
Journal:  J Lipid Res       Date:  1981-03       Impact factor: 5.922

8.  Distribution of apolipoprotein A-IV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin:cholesterol acyltransferase.

Authors:  J G DeLamatre; C A Hoffmeier; A G Lacko; P S Roheim
Journal:  J Lipid Res       Date:  1983-12       Impact factor: 5.922

9.  Serum lipoproteins of diabetic rats fed a high cholesterol diet.

Authors:  C M Arbeeny; D Edelstein; S R Freedman; H A Eder
Journal:  Diabetes       Date:  1980-10       Impact factor: 9.461

10.  Evidence for a new cause of defective plasma removal of very low density lipoproteins in insulin-deficient rats.

Authors:  H Bar-On; Y D Chen; G M Reaven
Journal:  Diabetes       Date:  1981-06       Impact factor: 9.461

View more
  9 in total

Review 1.  Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Authors:  Nosratola D Vaziri
Journal:  Kidney Int       Date:  2016-04-26       Impact factor: 10.612

Review 2.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

3.  Effects of low casein and fish oil on hyperlipidemia and proteinuria in nephritic rats.

Authors:  K Fujisawa; K Yagasaki; R Funabiki
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

4.  HDL and Kidney Diseases.

Authors:  Huanhuan Cao; Xia Meng
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Clinical Efficacy of Persian Medicine Diet Combined with Western Medicine-Based Diet on Proteinuria in Pediatric Nephrotic Syndrome: A Randomized Controlled Clinical Trial.

Authors:  Alireza Rahmani; Mohsen Naseri; Masoumeh Mohkam; Monireh Sadat Motaharifard; Mahsa Bakhtiary; Nezhat Shakeri; Reza Ilkhani
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-24       Impact factor: 2.650

Review 6.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 7.  HDL abnormalities in nephrotic syndrome and chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

8.  Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome.

Authors:  Seungyeup Han; Nosratola D Vaziri; Pavan Gollapudi; Vincent Kwok; Hamid Moradi
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

9.  Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease.

Authors:  Jin Hui Tang; Yu Wen; Fei Wu; Xiao Y Zhao; Mei X Zhang; Jie Mi; Katherine Cianflone
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.